BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9065170)

  • 1. The maternal-fetal transfer of lamivudine in the ex vivo human placenta.
    Bloom SL; Dias KM; Bawdon RE; Gilstrap LC
    Am J Obstet Gynecol; 1997 Feb; 176(2):291-3. PubMed ID: 9065170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ex vivo transfer of the anti-HIV nucleoside compound d4T in the human placenta.
    Bawdon RE; Kaul S; Sobhi S
    Gynecol Obstet Invest; 1994; 38(1):1-4. PubMed ID: 7959316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model.
    Casey BM; Bawdon RE
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):758-61. PubMed ID: 9757985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta.
    Bawdon RE; Sobhi S; Dax J
    Am J Obstet Gynecol; 1992 Dec; 167(6):1570-4. PubMed ID: 1335207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3'-azido-3'-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT.
    Olivero OA; Parikka R; Poirier MC; Vähäkangas K
    Mutat Res; 1999 Jul; 428(1-2):41-7. PubMed ID: 10517977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo human placental transfer of trovafloxacin.
    Casey B; Bawdon RE
    Infect Dis Obstet Gynecol; 2000; 8(5-6):228-9. PubMed ID: 11220482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and toxicity studies of AZT (zidovudine) following perfusion of human term placenta for 14 hours.
    Boal JH; Plessinger MA; van den Reydt C; Miller RK
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):13-21. PubMed ID: 9073587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of zidovudine and lamivudine from rat tissues by liquid chromatography/tandem mass spectrometry.
    Alnouti Y; Lewis SR; White CA; Bartlett MG
    Rapid Commun Mass Spectrom; 2005; 19(4):503-8. PubMed ID: 15678520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of lamivudine.
    Johnson MA; Moore KH; Yuen GJ; Bye A; Pakes GE
    Clin Pharmacokinet; 1999 Jan; 36(1):41-66. PubMed ID: 9989342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of inflammatory cytokines across the placenta.
    Zaretsky MV; Alexander JM; Byrd W; Bawdon RE
    Obstet Gynecol; 2004 Mar; 103(3):546-50. PubMed ID: 14990420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.
    Mandelbrot L; Peytavin G; Firtion G; Farinotti R
    Am J Obstet Gynecol; 2001 Jan; 184(2):153-8. PubMed ID: 11174495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of zidovudine (AZT) by human placenta.
    Liebes L; Mendoza S; Wilson D; Dancis J
    J Infect Dis; 1990 Feb; 161(2):203-7. PubMed ID: 2299205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo maternal-fetal-amniotic fluid pharmacokinetics of zidovudine in the pigtailed macaque: comparison of steady-state and single-dose regimens.
    Tuntland T; Odinecs A; Nosbisch C; Unadkat JD
    J Pharmacol Exp Ther; 1998 Apr; 285(1):54-62. PubMed ID: 9535994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo human placental transfer and the vasoactive properties of hydralazine.
    Magee KP; Bawdon RE
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):167-9. PubMed ID: 10649174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
    Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
    Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental transfer of elvitegravir and cobicistat in an ex-vivo human cotyledon double perfusion model.
    Faure-Bardon V; Mandelbrot L; Duro D; Dussaux C; Le M; Peytavin G
    AIDS; 2018 Jan; 32(3):321-325. PubMed ID: 29112064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.
    Mandelbrot L; Ceccaldi PF; Duro D; Lê M; Pencolé L; Peytavin G
    PLoS One; 2019; 14(8):e0220323. PubMed ID: 31408460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplacental passage of vancomycin in the ex vivo human perfusion model.
    Hnat MD; Gainer J; Bawdon RE; Wendel GD
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):57-61. PubMed ID: 15739818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus.
    Tuntland T; Odinecs A; Pereira CM; Nosbisch C; Unadkat JD
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):198-206. PubMed ID: 9914604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental transfer of Zidovudine in first trimester of pregnancy.
    Siu SS; Yeung JH; Pang MW; Chiu PY; Lau TK
    Obstet Gynecol; 2005 Oct; 106(4):824-7. PubMed ID: 16199642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.